326480-16-4

Upstream product

• 2746-25-0 p-Methoxybenzyl bromide 
• 824-94-2 p-methoxybenzyl chloride 
• 366491-40-9 4-methoxybenzyl phosphine 

Relevant academic research and scientific papers

AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.

Design and pharmacological activity of phosphinic acid based NAALADase inhibitors

A novel series of phosphinic acid based inhibitors of the neuropeptidase NAALADase are described in this work. This series of compounds is the most potent series of inhibitors of the enzyme described to date. In addition, we have shown that these compounds are protective in animal models of neurodegeneration. Compound 34 significantly prevented neurodegeneration in a middle cerebral artery occlusion model of cerebral ischemia. In addition, in the chronic constrictive model of neuropathic pain, compound 34 significantly attenuated the hypersensitivity observed with saline-treated animals. These data suggest that NAALADase inhibition may provide a new approach for the treatment of both neurodegenerative disorders and peripheral neuropathies.

Reactions of elemental phosphorus and phosphine with electrophiles in superbasic media: XI. Phosphorylation of 4-methoxybenzyl chloride with elemental phosphorus and phosphine

4-Methoxybenzyl chloride reacts with elemental (red or white) phosphorus under the conditions of phase-transfer catalysis (concentrated aqueous KOH, dioxane, benzyltriethylammonium chloride, 85-90°C, argon) to give as major product tris(4-methoxybenzyl)ph